Evidence map›Paper›PMID 41493399›Full record

ArticleeLife2026

Decoding the biogenesis of HIV-induced CPSF6 puncta and their fusion with nuclear speckles.

Chiara Tomasini, Celine Cuche, Selen Ay, Maxence Collard, Bin Cui, Mohammad Rashid, Shaoni Bhattacharjee, Bruno Tello-Rubio, Julian Buchrieser, Charlotte Luchsinger and 4 more

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Chiara Tomasini *Institut Pasteur, Advanced Molecular Virology Unit, Department of Virology, Université Paris Cité, Paris, France.
Celine Cuche *Institut Pasteur, Advanced Molecular Virology Unit, Department of Virology, Université Paris Cité, Paris, France.
Selen AyInstitut Pasteur, Advanced Molecular Virology Unit, Department of Virology, Université Paris Cité, Paris, France.
Maxence CollardInstitut Pasteur, Advanced Molecular Virology Unit, Department of Virology, Université Paris Cité, Paris, France.
Bin CuiAlbert Einstein College of Medicine, Department of Immunology and Microbiology, New York, United States.
Mohammad RashidAlbert Einstein College of Medicine, Department of Immunology and Microbiology, New York, United States.
Shaoni BhattacharjeeInstitut Pasteur, Advanced Molecular Virology Unit, Department of Virology, Université Paris Cité, Paris, France.
Bruno Tello-RubioInstitut Pasteur, Advanced Molecular Virology Unit, Department of Virology, Université Paris Cité, Paris, France.
Julian BuchrieserInstitut Pasteur, Virus and Immunity Unit, Department of Virology, Université Paris Cité, Paris, France.
Charlotte LuchsingerAlbert Einstein College of Medicine, Department of Immunology and Microbiology, New York, United States.
Cinzia BertelliAlbert Einstein College of Medicine, Department of Immunology and Microbiology, New York, United States.
Vladimir UverskyDepartment of Molecular Medicine and USF Health Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South Florida, Tampa, United States.
Felipe Diaz-GrifferoAlbert Einstein College of Medicine, Department of Immunology and Microbiology, New York, United States.ORCID https://orcid.org/0000-0002-7021-6152
Francesca Di NunzioInstitut Pasteur, Advanced Molecular Virology Unit, Department of Virology, Université Paris Cité, Paris, France.ORCID https://orcid.org/0000-0003-2879-3164

Funding

Role of Cellular Factors in Retroviral Uncoating and Synthesis of Viral DNAR01AI087390 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI DIAZ-GRIFFERO, FELIPE · 2010 to 2024
$6.8M
Regulation of SAMHD1 antiviral activityR01AI150455 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI DIAZ-GRIFFERO, FELIPE · 2019 to 2024
$3.3M
Agence Nationale de Recherches sur le Sida et les Hépatites Virales ECTZ137593Agence Nationale de Recherches sur le Sida et les Hépatites Virales ECTZ192036Agence Nationale de Recherches sur le Sida et les Hépatites Virales ECTZ204694Agence Nationale de Recherches sur le Sida et les Hépatites Virales ECTZ290008NIH HHS R01AI087390NIH HHS R01AI150455
6 · The paper itself

Abstract

Viruses rely on host cellular machinery for replication. After entering the nucleus, the HIV genome accumulates in nuclear niches where it undergoes reverse transcription and integrates into neighbouring chromatin, promoting high transcription rates and new virus progeny. Despite antiretroviral treatment, viral genomes can persist in these nuclear niches and reactivate upon treatment interruption, raising the possibility that they could play a role in the establishment of viral reservoirs. The post-nuclear entry dynamics of HIV remain unclear, and understanding these steps is critical for revealing how viral reservoirs are established. In this study, we elucidate the formation of HIV-induced CPSF6 puncta and the domains of CPSF6 essential for this process. We also explore the roles of nuclear speckle (NS) scaffold factors, SON and SRRM2, in the biogenesis of these puncta. Through genetic manipulation and depletion experiments, we demonstrate the key role of the intrinsically disordered region of SRRM2 in enlarging NSs in the presence of the HIV capsid. We identify the FG domain of CPSF6 as essential for both puncta formation and binding to the viral core, which serves as the scaffold for CPSF6 puncta. While the low-complexity regions modulate CPSF6 binding to the viral capsid, they do not contribute to puncta formation, nor do the disordered mixed charge domains of CPSF6. Interestingly, the FG peptide facilitates viral replication. These results demonstrate how HIV evolved to hijack host nuclear factors, enabling its persistence in the host. Of note, this study provides new insights into the underlying interactions between host factors and viral components, advancing our understanding of HIV nuclear dynamics and offering potential therapeutic targets for preventing viral persistence.

Indexed as

Cell NucleusHIV-1HIV InfectionsmRNA Cleavage and Polyadenylation FactorsHEK293 CellsHeLa CellsHumansVirus Replicationcleavage factor Im, humanmRNA Cleavage and Polyadenylation Factorscell biologycondensatesHIVinfectious diseasemicrobiologynuclear specklesnucleuspost-nuclear entryviruses

Identifiers

PMID41493399
PMCPMC12774418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.